Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC)
Clinical trial NCT06384820 · WITHDRAWN
Trial details
- NCT number
- NCT06384820
- Sponsor
- Regeneron Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-14
- Primary completion
- 2026-06-08
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.